UNSPSC 51333103: Panamesine

This classification denotes an antipsychotic agent with the molecular formula C23H26N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 023D9E916L chemically known as (5s)-5-((4-hydroxy-4-(3,4-(methylenedioxy)phenyl)piperidino)methyl)-3-(p-methoxyphenyl)-2-oxazolidinone but generally known as panamesine, which bears US NIH Compound Identifier 3047810. European Medicines Agency schedules Panamesine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09601MIG.

UNSPSC 51333103 Panamesine is a Commodity code under which state and local governments procure naloxone and drug deactivation systems for community health and opioid-response initiatives. The scope encompasses the acquisition of pharmaceutical harm-reduction products and related equipment, with vendors supplying these items on recurring annual schedules to support local public-health programs. Issuing bodies soliciting under this code include county health departments and community health agencies managing opioid-crisis response and emergency-preparedness initiatives. Procurement activity reflects the expanding role of state and local jurisdictions in addressing substance-use disorders through direct acquisition of life-saving medications and drug disposal infrastructure.

Seminole County, Florida posted an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug-deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida and a response deadline of July 26, 2023. The contract carries a two-year initial term with a one-year renewal option, fixed-fee pricing, standard insurance and E-Verify compliance requirements, and a three-month probationary termination clause. The procurement identified potential FEMA funding, triggering federal environmental-compliance obligations. The code shows limited recent activity in the available dataset, with a single representative opportunity; geographic concentration and broader issuing-body patterns cannot be reliably characterized from this single posting.